
Hermis Liber Pharmaceuticals Private Limited
About Hermis Liber Pharmaceuticals Private Limited
Data last updated:
Hermis Liber Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the medical and surgical equipment segment of the healthcare sector. It was incorporated on 02 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33119UP2018PTC099901. Its GSTIN is 09AAECH4031K1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Eshrat Begum and Shahid Ali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12/B Ankur Appartment, Ghaziabad, Uttar Pradesh, India – 201005.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.85 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹7,817 (net margin -2%) and EBITDA of -₹7,817 (EBITDA margin -2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over five years.
Company details
Contact details
Hermis Liber Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address12/B Ankur Appartment, Ghaziabad, Uttar Pradesh, India – 201005
- IndustryHealthcare, Medical & Surgical Equipment, Manufacturing, Orthopedic Appliances, Other Medical And Surgical Equipment, Medical Appliances And Instruments
To see the full contact details of Hermis Liber Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hermis Liber Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hermis Liber Pharmaceuticals Private Limited, buy the company report.
Financials of Hermis Liber Pharmaceuticals Private Limited
FY 2025 filings availableHermis Liber Pharmaceuticals Private Limited reported revenue of ₹3.85 Lakh (down 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7,817 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7,817 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hermis Liber Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hermis Liber Pharmaceuticals Private Limited
Hermis Liber Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Eshrat Begum | Director | 02 Jan 2018 | 8 Years 10 Months | Current |
| Shahid Ali | Director | 02 Jan 2018 | 8 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Hermis Liber Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hermis Liber Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hermis Liber Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECH4031K1ZL | Uttar Pradesh | Active | 30 Nov 2021 |
To see the full GST registrations and return filing status of Hermis Liber Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hermis Liber Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Eshrat Begum was appointed as Director on 02 Jan 2018.
Frequently asked questions
Hermis Liber Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in medical and surgical equipment, within the healthcare industry. It was incorporated on 02 January 2018 (8+ years old) and is registered under CIN U33119UP2018PTC099901.
Hermis Liber Pharmaceuticals has 2 current directors:
- Eshrat Begum - Director
- Shahid Ali - Director
The latest financial statements of Hermis Liber Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Hermis Liber Pharmaceuticals is 09AAECH4031K1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Hermis Liber Pharmaceuticals is U33119UP2018PTC099901. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hermis Liber Pharmaceuticals was incorporated on 02 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Eshrat Begum was appointed as Director on 02 Jan 2018. Shahid Ali was appointed as Director on 02 Jan 2018.
The registered office of Hermis Liber Pharmaceuticals is at 12B Ankur Appartment, Ghaziabad, Uttar Pradesh, India – 201005.
Hermis Liber Pharmaceuticals operates in the healthcare industry, in the medical and surgical equipment segment.
Hermis Liber Pharmaceuticals can be reached at its registered office: 12B Ankur Appartment, Ghaziabad, Uttar Pradesh, India – 201005.

